Benedetta Ferrara
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Corrigendum to "The nucleolin antagonist N6L and paclitaxel combination treatment could be a new promising therapeutic strategy for pancreatic ductal adenocarcinoma therapy" [Eur. J. Pharmacol. 991 (2025) 177310].
Journal: European journal of pharmacology
Published: February 28, 2025
ASO Author Reflections: Bridging the Gap in PDAC Research: The Intraportal Model as a Platform for Studying Preclinical Liver Metastasis.
Journal: Annals of surgical oncology
Published: May 31, 2024
Establishment of a Transplantation Model of PDAC-Derived Liver Metastases.
Journal: Annals of surgical oncology
Published: February 26, 2024
A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma.
Journal: International journal of molecular sciences
Published: August 10, 2022
A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins.
Journal: International journal of biological sciences
Published: June 07, 2022
Cell surface nucleolin as active bait for nanomedicine in cancer therapy: a promising option.
Journal: Nanotechnology
Published: December 22, 2020
Fabrication of large pore mesoporous silica microspheres by salt-assisted spray-drying method for enhanced antibacterial activity and pancreatic cancer treatment.
Journal: International journal of pharmaceutics
Published: July 30, 2020
Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 09, 2019
Last Updated: 09/26/2026